Bristol-Myers Squibb Co. (BMY) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $61.28 -0.65%
Revenue Growth %: +4.3%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
OMID, BCML, CZNC, More
Revenue Growth %: +4.3%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.01 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $4.44 billion versus the consensus estimate of $4.44 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plumas Bancorp (PLBC) Tops Q3 EPS by 15c
- First Community Corp. (FCCO) Tops Q3 EPS by 5c
- GE Vernova rises on BofA order growth forecast
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
